Results 251 to 260 of about 85,625 (273)

Cernilton for benign prostatic hyperplasia

Cochrane Database of Systematic Reviews, 1998
Benign prostatic hyperplasia (BPH), nonmalignant enlargement of the prostate, can lead to obstructive and irritative lower urinary tract symptoms (LUTS). The pharmacologic use of plants and herbs (phytotherapy) for the treatment of LUTS associated with BPH has been growing steadily.
Timothy J Wilt, Indy Rutks, Roderick MacDonald, Areef Ishani, Gerold Stark   +4 more
openaire   +5 more sources

Terazosin for benign prostatic hyperplasia

Cochrane Database of Systematic Reviews, 2000
Lower urinary tract symptoms associated with benign prostatic obstruction (BPO) occur in up to 70% of men over the age of 60 years. To relieve these bothersome symptoms, treatment options include alpha-antagonists, also know as alpha-blockers.We conducted a systematic review to evaluate the effectiveness and adverse effects of the alpha-blocker ...
Indy Rutks, Timothy J Wilt, Roderick MacDonald, R William Howe   +3 more
openaire   +5 more sources

Tamsulosin for benign prostatic hyperplasia

Cochrane Database of Systematic Reviews, 2002
Benign prostatic hyperplasia (BPH) is a nonmalignant enlargement of the prostate which can result in bothersome lower urinary tract symptoms. The treatment goal for men with BPH is to relieve these bothersome symptoms.This systematic review assessed the effects of tamsulosin in the treatment of lower urinary tract symptoms (LUTS) compatible with BPH ...
Indy Rutks, Roderick MacDonald, Timothy J Wilt   +2 more
openaire   +3 more sources

Benign Prostatic Hyperplasia

Clinics in Geriatric Medicine, 2010
This article reviews the epidemiology of benign prostatic hyperplasia (BPH), evaluation of patients with lower urinary tract symptomatology (LUTS), and management of patients with BPH and LUTS. The evaluation includes history and physical examination, laboratory testing, and specialized studies.
openaire   +2 more sources

Finasteride for benign prostatic hyperplasia

Cochrane Database of Systematic Reviews, 2009
Benign prostatic hyperplasia (BPH), a non-malignant enlargement of the prostate in aging men, can cause bothersome urinary symptoms (intermittency, weak stream, straining, urgency, frequency, incomplete emptying). Finasteride, a five-alpha reductase inhibitor (5ARI), blocks the conversion of testosterone to dihydrotestosterone, reduces prostate size ...
Timothy J Wilt, James Tacklind, Roderick MacDonald, Howard A Fink, Indy Rutks   +4 more
openaire   +3 more sources

Herbs for Benign Prostatic Hyperplasia

Annals of Pharmacotherapy, 2002
OBJECTIVE: To review and evaluate the literature relative to the use of herbal therapies in the treatment of benign prostatic hyperplasia. DATA SOURCES: Literature was identified by MEDLINE, Embase, International Pharmaceutical Abstracts, and the International Bibliographic Information on Dietary Supplements searches and through cross-referencing of ...
Lana Dvorkin, Kathy Y Song
openaire   +2 more sources

Testosterone and Benign Prostatic Hyperplasia

Sexual Medicine Reviews, 2019
Benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS) are frequent in aging. Nonetheless, their pathogenesis is largely unknown. The androgen dependence of the first phases of prostate development have inspired the historical view that higher testosterone (T) may be involved in BPH occurrence; however, recent evidence suggests a ...
Rastrelli G, Vignozzi L, Corona G, Maggi M   +3 more
openaire   +4 more sources

Investigation of benign prostatic hyperplasia

Current Opinion in Urology, 2003
This is a concise and timely update of the most recent developments in the clinical research on the investigation of benign prostatic hyperplasia.Analysis of the peer-review literature confirms a high level of consensus as to the management of prostatic hyperplasia; analysis of practice trends suggests a satisfactory degree of adoption of the proposed ...
TUBARO, ANDREA, TRUCCHI, Alberto, MIANO, Lucio   +2 more
openaire   +4 more sources

[Prostatic benign hyperplasia].

Acta medica portuguesa, 2001
After reviewing the clinical, diagnostic and therapeutic attitude related to Benign Prostatic Hyperplasia, the authors present the guidelines for Generalists, in terms of practical handling and when and how to refer their patients to the Urology consultation.
M J Carmona Luís, M J Abreu, J L Fuente De Carvalho, M Mendes Silva, A Sismeiro, L Campos Pinheiro, M T Catalão Castro   +6 more
openaire   +3 more sources

BENIGN PROSTATIC HYPERPLASIA (THE AGING PROSTATE)

Medical Clinics of North America, 1999
BPH is a common phenomenon of the aging process. Clinical manifestations may range from minimally bothersome symptoms to urinary retention and renal failure. Tailoring of treatment based on the individual patient is required for successful management. For mild symptoms, watchful waiting is a valid option.
Robert G. Moore, Juan J. Medina, Raul O. Parra   +2 more
openaire   +3 more sources